Stage I Bladder Cancer AJCC v8
12 clinical trials · Condition
◉ Watch Stage I Bladder Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship (NCT04548193) | Roswell Park Cancer Institute | 2021-04-05 |
| Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer (NCT04496219) | Fred Hutchinson Cancer Center | 2021-01-22 |
| Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (NCT04164082) | National Cancer Institute (NCI) | 2020-03-18 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study (NCT06350734) | Mayo Clinic | 2018-10-12 |
| Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745) | M.D. Anderson Cancer Center | 2018-01-11 |
Track Stage I Bladder Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.